Phase 2b Study of ALTO-100 in MDD

NCT05712187 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: ALTO-100
DRUG: Placebo

Sponsor

Alto Neuroscience